CLASS II Device recall · Reported 26 Sep 2018 · FDA Enforcement Report

AIRO Mobile CT System recalled by Mobius Imaging

Mobius Imaging is recalling AIRO Mobile CT System. The recall was initiated on 1 Aug 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesModel # MobiCT-32
Quantity recalled147

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2991-2018
FDA event ID
80867
Recalling firm
Mobius Imaging, Shirley, MA
Classification
Class II
Status
Terminated
Recall initiated
1 Aug 2018
FDA classified
14 Sep 2018
Reported
26 Sep 2018
Type
FDA Mandated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

1 Aug 2018Recall initiated by company
14 Sep 2018Classified by FDA+44 days
26 Sep 2018Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The Tube Current Modulation feature (Modulated Scans) is not working in AIRO systems with software version 2.0.0.0, and operators would not be able to detect this fault until after a scan is completed.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

AIRO Mobile CT System Model # MobiCT-32

Where it was distributed

US and foreign distribution.

Questions about this recall

Why was it recalled?

The Tube Current Modulation feature (Modulated Scans) is not working in AIRO systems with software version 2.0.0.0, and operators would not be able to detect this fault until after a scan is completed.

Which lots are affected?

Model # MobiCT-32

Where was it sold?

US and foreign distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Mobius Imaging

All 7

Other Other Medical Devices recalls

All 13,908